SCHEMBL13740230

SCHEMBL13740230

CC(C)(CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1cc(C(=O)O)n[nH]1)C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11969137 1.00 MME (0.70) MME
SCHEMBL11969823 0.93 MME (0.81) MME
SCHEMBL11969825 0.93 MME (0.81) MME
SCHEMBL11969807 0.92 MME (0.68) MME
SCHEMBL11969799 0.92 MME (0.68) MME
SCHEMBL11969246 0.91 MME (0.69) MME
SCHEMBL11969250 0.91 MME (0.69) MME
SCHEMBL11969847 0.91 MME (0.66) MME
SCHEMBL11969842 0.91 MME (0.66) MME
SCHEMBL11969881 0.89 MME (0.88) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675792-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-12-25 — — EP disclosed
WO-2012154249-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-11-15 — — WO disclosed
Send feedback